New Drug Development & Regulatory News
Bora division partners with TaiRx to manufacture anticancer drug
Bora Pharmaceutical Laboratories, a division of Bora Pharmaceuticals has partnered with TaiRx, a Taiwan new drug development company, to manufacture a novel anticancer drug, CVM-1118. Read more
27 Sep 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
Aptar and Fluidda collab to accelerate regulatory pathway for OINDPs
Nanopharm, an Aptar Pharma company in contract research and development services for orally inhaled and nasal drug products (OINDPs), announced an exclusive collaboration with Fluidda, a specialist in the field of Functional Respiratory Imaging. Read more
26 Sep 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
New biopharma standard to provide guidance for continuous manufacturing
ASTM International’s manufacture of pharmaceutical and biopharmaceutical products committee (E55) has approved a new standard that will help advance the use of continuous manufacturing (CM) technologies in the biopharma industry. Read more
23 Sep 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
Terumo BCT bioreactor platform to support cell therapy commercialisation
Terumo Blood and Cell Technologies (Terumo BCT) announced the launch of its Quantum Flex Cell Expansion System, a bioreactor platform that supports process development through to commercial manufacturing for the CGT sector. Read more
21 Sep 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
EC approve first oral treatment for active lupus nephritis
Otsuka Pharmaceutical Europe announce the EC has approved Lupkynis (voclosporin) in combination with mycophenolate mofetil for the treatment of adult patients with active class III, IV or V (including mixed class III/V and IV/V) lupus nephritis (LN). Read more
20 Sep 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
Drug combo meets survival endpoint in Phase III trial for colorectal cancer
Servier, Taiho Oncology and Pharmaceutical announced that the investigational combination of trifluridine/tipiracil plus bevacizumab showed a statistically significant improvement in the primary endpoint of overall survival (OS) in colorectal cancer. Read more
15 Sep 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
Sponsored Content
![_PPD7787[16257735][21] copy.png](https://pharmaceuticalmanufacturer.media/downloads/9090/download/_PPD7787%5B16257735%5D%5B21%5D%20copy.png?cb=c1124c7feb9e0df370cb35e0e94f7164&w=640 "_PPD7787[16257735][21] copy.png")
Debut event showcased newest trends in drug manufacturing and delivery
Connect in Pharma had its debut launch on 14 & 15 September in Geneva. Key companies in the pharma industry came together during the two-day event to hear about the latest innovations and developments in pharma manufacturing and drug delivery. Read more
23 Sep 2022
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Pistoia Alliance and FDA collaborate to accelerate regulatory submissions
Pistoia Alliance has announced the creation of a new In Vitro Pharmacology Working Group, in collaboration with the US FDA, that aims to improve the data structures and standards for in vitro pharmacology (IVP) data in regulatory submissions. Read more
15 Sep 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
![DSC_3254[4] copy.png](https://pharmaceuticalmanufacturer.media/downloads/9058/download/DSC_3254%5B4%5D%20copy.png?cb=8f44b4cf010700b77cb30f8079f379ec&w=640 "DSC_3254[4] copy.png")
Studio Imagine � 2022 Studio Imagine, all rights reserved.
MGI launches high-throughput sequencing kit at genome conference
At the 17th International Conference of Genomics (ICG-17) on 7-9 September in Riga, Latvia, MGI introduced its new commercial sequencing chemistry HotMPS and together with BGI STOmics, a spatial transcriptomics grant program. Read more
12 Sep 2022
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
![_PPD7787[16257735][21] copy.png](https://pharmaceuticalmanufacturer.media/downloads/9090/download/_PPD7787%5B16257735%5D%5B21%5D%20copy.png?cb=c1124c7feb9e0df370cb35e0e94f7164&w={width}&h={height} "_PPD7787[16257735][21] copy.png")
![DSC_3254[4] copy.png](https://pharmaceuticalmanufacturer.media/downloads/9058/download/DSC_3254%5B4%5D%20copy.png?cb=8f44b4cf010700b77cb30f8079f379ec&w={width}&h={height} "DSC_3254[4] copy.png")
Vaccine skin patch receives second round funding grant
Vaxxas will receive an AU$8.2 million second round grant as part of the Australian Federal Government’s Modern Manufacturing Initiative (MMI) to support the manufacturing scale-up of its vaccine delivery technology. Read more
28 Sep 2022
AstraZeneca treatment lowers cardiovascular death in HF patients
AstraZeneca recently released results from two key studies at the European Society of Cardiology (ESC) Congress 2022 in Barcelona, Spain, validating the clinical value and differentiation of FARXIGA in treating patients living with heart failure. Read more
28 Sep 2022
WuXi opens first high potency oral drug product manufacturing facility
WuXi STA, a global CRDMO, announced the opening of its first high potency (HP) oral drug product manufacturing facility at its Wuxi city campus. This new facility allows WuXi STA to further extend its drug product capacity and capabilities. Read more
28 Sep 2022
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Bora division partners with TaiRx to manufacture anticancer drug
Bora Pharmaceutical Laboratories, a division of Bora Pharmaceuticals has partnered with TaiRx, a Taiwan new drug development company, to manufacture a novel anticancer drug, CVM-1118. Read more
27 Sep 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
![_DSC1196 copy-min-min[94].png](https://pharmaceuticalmanufacturer.media/downloads/9107/download/_DSC1196%20copy-min-min%5B94%5D.png?cb=6027715905cf4c9b56b68f3cb0ccf2d5&w=640 "_DSC1196 copy-min-min[94].png")
Peli BioThermal opens new service centre in Japan
Peli BioThermal, the life science industry’s partner from discovery to distribution, announces the opening of its new service center in Japan. The new facility is ideally situated near Tokyo’s international Narita Airport. Read more
27 Sep 2022
Pharma Manufacturing News + Pharma Finance and Investment News
BioIVT acquires Fidelis Research to expand biospecimen capabilites
BioIVT, a provider of biospecimens, research models and services for drug and diagnostic development, has acquired Fidelis Research, an 85-site clinical biospecimen collection network in Southeastern Europe with headquarters in Sofia, Bulgaria. Read more
27 Sep 2022
![_DSC1196 copy-min-min[94].png](https://pharmaceuticalmanufacturer.media/downloads/9107/download/_DSC1196%20copy-min-min%5B94%5D.png?cb=6027715905cf4c9b56b68f3cb0ccf2d5&w={width}&h={height} "_DSC1196 copy-min-min[94].png")
Sponsored Content
Lonza - New Webinar: Solid Form Screening and Rapid Formulation Selection to Meet Demands of Accelerated Timelines
Compare formulation strategy advantages and disadvantages through case studies Read more
1 Jun 2022
White Papers
Sponsored Content
Sponsored Content
Lonza - New Webinar: Solid Form Screening and Rapid Formulation Selection to Meet Demands of Accelerated Timelines
Compare formulation strategy advantages and disadvantages through case studies Read more
1 Jun 2022
Russell Finex
Russell Finex is global leader in pharmaceutical sieving and filtration equipment Read more
